ISRAEL ISAAC

PrivateCIK: 2122471
InsiderISRAEL ISAACCIK 2122471
IssuerNASUS PHARMA LTDCIK 2029039
Director
Since Mar 2026
0.00
Baseline shares
0.00
Direct ownership
0 positions
10K
Derivative underlying
1 instrument
0
Security positions
All direct
Non-Derivative Holdings0
No non-derivative holdings reported
Derivative Holdings1

Share Option (right to buy)

Direct
Underlying security
Ordinary Shares

Underlying shares

10K

Shares owned

N/A

Exercise price

5.38

Expiration

Exercise window

Total

Underlying

10K

Owned

0.00

ISRAEL ISAAC — Initial Ownership Disclosure (Form 3) Filed Mar 27, 2026 | Finecho